Article
Multidisciplinary Sciences
Daniel J. Apicco, Evgeny Shlevkov, Catherine L. Nezich, David T. Tran, Edward Guilmette, Justin W. Nicholatos, Collin M. Bantle, Yi Chen, Kelly E. Glajch, Neeta A. Abraham, Lan T. Dang, G. Campbell Kaynor, Ellen A. Tsai, Khanh-Dung H. Nguyen, Joost Groot, YuTing Liu, Andreas Weihofen, Jessica A. Hurt, Heiko Runz, Warren D. Hirst
Summary: ITPKB is negatively regulating alpha-synuclein aggregation by inhibiting ER-to-mitochondria calcium transport, suggesting modulation of this pathway as a potential therapeutic strategy for sporadic PD.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2021)
Review
Biochemistry & Molecular Biology
Abbie T. Rodger, Maryam A. L. Nasser, Wayne G. Carter
Summary: Currently, there are no pharmacological treatments that can completely stop or reverse the progression of Parkinson's Disease (PD). Therefore, there is a need for neuroprotective therapies. This systematic review examines the effectiveness of anti-a-synuclein (a-syn) therapies in preventing PD progression in preclinical models and human clinical trials. The review found that novel preclinical anti-a-syn therapeutics reduced a-syn aggregations and protected against dopaminergic neuronal loss. Completed clinical trials showed significant tolerability and efficacy in reducing a-syn and minimal adverse effects. Overall, this review highlights the potential of anti-a-syn therapies in both preclinical and clinical settings to reduce a-syn accumulation and potentially slow down PD progression.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Medicine, General & Internal
G. Pagano, K. I. Taylor, J. Anzures-Cabrera, M. Marchesi, T. Simuni, K. Marek, R. B. Postuma, N. Pavese, F. Stocchi, J. -P. Azulay, B. Mollenhauer, L. Lopez-Manzanares, D. S. Russell, J. T. Boyd, A. P. Nicholas, M. R. Luquin, R. A. Hauser, T. Gasser, W. Poewe, B. Ricci, A. Boulay, A. Vogt, F. G. Boess, J. Dukart, G. D'Urso, R. Finch, S. Zanigni, A. Monnet, N. Pross, A. Hahn, H. Svoboda, M. Britschgi, F. Lipsmeier, E. Volkova-Volkmar, M. Lindemann, S. Dziadek, S. Holiga, D. Rukina, T. Kustermann, G. A. Kerchner, P. Fontoura, D. Umbricht, R. Doody, T. Nikolcheva, A. Bonni
Summary: The study found that prasinezumab had no meaningful effect on global or imaging measures of Parkinson's disease progression and was associated with infusion reactions.
NEW ENGLAND JOURNAL OF MEDICINE
(2022)
Article
Multidisciplinary Sciences
Hideaki Matsui, Shinji Ito, Hideki Matsui, Junko Ito, Ramil Gabdulkhaev, Mika Hirose, Tomoyuki Yamanaka, Akihide Koyama, Taisuke Kato, Maiko Tanaka, Norihito Uemura, Noriko Matsui, Sachiko Hirokawa, Maki Yoshihama, Aki Shimozawa, Shin-ichiro Kubo, Kenji Iwasaki, Masato Hasegawa, Ryosuke Takahashi, Keisuke Hirai, Akiyoshi Kakita, Osamu Onodera
Summary: This study found that phosphorylation of a-Synuclein at T64 was increased in both Parkinson's disease models and human PD brains. The T64D phosphomimetic mutation led to the formation of a-Synuclein oligomers with a similar structure to those with the A53T mutation, and it induced mitochondrial dysfunction, lysosomal disorder, cell death, and neurodegeneration. These findings suggest a pathogenic role of a-Synuclein phosphorylation at T64 in Parkinson's disease.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2023)
Review
Pharmacology & Pharmacy
Md Ezazul Haque, Mahbuba Akther, Shofiul Azam, In-Su Kim, Yuxi Lin, Young-Ho Lee, Dong-Kug Choi
Summary: In Parkinson's disease, the aggregated alpha-synuclein in Lewy bodies and mitochondrial dysfunction play crucial roles in neurodegeneration, with interactions between aggregated alpha-synuclein and mitochondria potentially leading to neuronal loss, making it an emerging drug target for Parkinson's disease treatment.
BRITISH JOURNAL OF PHARMACOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Mari Suzuki, Kazunori Sango, Yoshitaka Nagai
Summary: Alpha-synuclein plays a major role in the pathogenesis of Parkinson's disease, and fruit fly models expressing alpha-synuclein contribute to the understanding of disease-associated factors.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Cell Biology
Fei Gao, Han Zhang, Jia Yang, Menghua Cai, Qi Yang, Huaishan Wang, Yi Xu, Hui Chen, Yu Hu, Wei He, Jianmin Zhang
Summary: This study reveals the critical role of the AAA + ATPase Thorase in neuroprotection and synaptic plasticity. It interacts with alpha-synuclein and regulates its degradation, providing further insights into the pathogenesis of alpha-synucleinopathies including Parkinson's disease.
Article
Multidisciplinary Sciences
Yunseon Yang, Jae-Jin Song, Yu Ree Choi, Seong-Hoon Kim, Min-Jong Seok, Noviana Wulansari, Wahyu Handoko Wibowo Darsono, Oh-Chan Kwon, Mi-Yoon Chang, Sang Myun Park, Sang-Hun Lee
Summary: Astrocytes have therapeutic potential in alleviating α-synuclein pathology in Parkinson's disease by regulating neuronal α-syn proteostasis and correcting inflammatory environments.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2022)
Article
Neurosciences
Jiaolong Yang, Shilin Luo, Jichun Zhang, Ting Yu, Zhihui Fu, Yongfa Zheng, Ximing Xu, Chaoyang Liu, Mingxia Fan, Zhentao Zhang
Summary: This study demonstrated that exosome-mediated delivery of ASO4 could effectively reduce alpha-synuclein expression, attenuate its aggregation, and improve locomotor functions in a transgenic model of Parkinson's disease.
NEUROBIOLOGY OF DISEASE
(2021)
Review
Biochemistry & Molecular Biology
Eun Hae Kwon, Sabrina Tennagels, Ralf Gold, Klaus Gerwert, Leon Beyer, Lars Toenges
Summary: This paper emphasizes the importance of reliable objective markers for identifying individuals at risk of Parkinson's disease. Advances in biomarker discovery, particularly in the cerebrospinal fluid (CSF), have provided promising preliminary results. Potential biomarkers include alpha-synuclein species, markers of amyloid and tau pathology, neurofilament light chain, lysosomal enzymes, and markers of neuroinflammation. Metabolomics approaches have also offered insights into novel biological pathways. Genetic forms of PD can help identify subgroups suitable for targeted treatments. Further validation studies are needed to determine the most valuable CSF biomarkers or combinations for clinical and research purposes.
Article
Clinical Neurology
Ying Meng, Christopher B. Pople, Yuexi Huang, Ryan M. Jones, Julie Ottoy, Maged Goubran, Lais M. Oliveira, Benjamin Davidson, Liam S. P. Lawrence, Angus Z. Lau, Allison Bethune, Pejman Maralani, Agessandro Abrahao, Clement Hamani, Kullervo Hynynen, Suneil K. Kalia, Nir Lipsman, Lorraine V. Kalia
Summary: This study demonstrates the safety and feasibility of MRgFUS GCase delivery in PD and supports further investigation of this approach.
MOVEMENT DISORDERS
(2022)
Review
Biochemistry & Molecular Biology
Luca Magistrelli, Elena Contaldi, Francesca Vignaroli, Silvia Gallo, Federico Colombatto, Roberto Cantello, Cristoforo Comi
Summary: Parkinson's disease is a neurodegenerative disease characterized by loss of dopaminergic neurons. Recent studies have shown that immune system hyperactivation and production of pro-inflammatory cytokines are signature features of idiopathic Parkinson's disease. Genetic factors may also play a role in some patients.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Review
Biochemistry & Molecular Biology
Milena Fais, Antonio Dore, Manuela Galioto, Grazia Galleri, Claudia Crosio, Ciro Iaccarino
Summary: Parkinson's disease is a complex neurodegenerative disorder with causes attributed to both genetic and environmental factors. Lipids play a significant role in the pathological pathways of PD, potentially contributing to neuronal toxicity through protein alterations.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Biochemistry & Molecular Biology
Mingxia Bi, Xixun Du, Xue Xiao, Yingying Dai, Qian Jiao, Xi Chen, Lingqiang Zhang, Hong Jiang
Summary: The overexpression of alpha-Syn was found to reduce immunoproteasome function, exacerbating phosphorylation and aggregation, ultimately leading to neurodegeneration in Parkinson's Disease.
Review
Medicine, Research & Experimental
Qianhui Huang, Pei Yang, Yang Liu, Jianhua Ding, Ming Lu, Gang Hu
Summary: Alpha-Synuclein, a member of the synuclein protein family, plays an important role in the formation and transmission of nerve synapses. Its abnormal aggregation is recognized as one of the important factors leading to neuroinflammation in Parkinson's disease. This study investigated the influence of post translational modification of alpha-Syn on its pathological aggregation and summarized various pathways that activate NLRP3 triggered by alpha-Syn and targeted therapeutic strategies.
BIOMEDICINE & PHARMACOTHERAPY
(2023)
Article
Biochemistry & Molecular Biology
Jaroslav Truksa, Lan-Feng Dong, Jakub Rohlena, Jan Stursa, Magdalena Vondrusova, Jacob Goodwin, Maria Nguyen, Katarina Kluckova, Zuzana Rychtarcikova, Sandra Lettlova, Jana Spacilova, Michael Stapelberg, Mario Zoratti, Jiri Neuzil
ANTIOXIDANTS & REDOX SIGNALING
(2015)
Article
Cell Biology
An S. Tan, James W. Baty, Lan-Feng Dong, Ayenachew Bezawork-Geleta, Berwini Endaya, Jacob Goodwin, Martina Bajzikova, Jaromira Kovarova, Martin Peterka, Bing Yan, Elham Alizadeh Pesdar, Margarita Sobol, Anatolyj Filimonenko, Shani Stuart, Magdalena Vondrusova, Katarina Kluckova, Karishma Sachaphibulkij, Jakub Rohlena, Pavel Hozak, Jaroslav Truksa, David Eccles, Larisa M. Haupt, Lyn R. Griffiths, Jiri Neuzil, Michael V. Berridge
Article
Neurosciences
Rowan Radford, Alex Rcom-H'cheo-Gauthier, Mathew B. Wong, Emma D. Eaton, Marion Quilty, Catherine Blizzard, Anwar Norazit, Adrian Meedeniya, James C. Vickers, Wei Ping Gai, Gilles J. Guillemin, Adrian K. West, Tracey C. Dickson, Roger Chung, Dean L. Pountney
MOLECULAR AND CELLULAR NEUROSCIENCE
(2015)
Article
Oncology
Fuad Bahram, Per Hydbring, Susanna Tronnersjo, Siti Mariam Zakaria, Oliver Frings, Sara Fahlen, Helen Nilsson, Jacob Goodwin, Natalie von der Lehr, Yingtao Su, Bernhard Luescher, Alina Castell, Lars-Gunnar Larsson
Correction
Multidisciplinary Sciences
Elham Alizadeh Pasdar, Michael Smits, Michael Stapelberg, Martina Bajzikova, Marina Stantic, Jacob Goodwin, Bing Yan, Jan Stursa, Jaromira Kovarova, Karishma Sachaphibulkij, Ayenachew Bezawork-Geleta, Margaryta Sobol, Anatoly Filimonenko, Marco Tomasetti, Renata Zobalova, Pavel Hozak, Lan-Feng Dong, Jiri Neuzil
Article
Oncology
Marco Tomasetti, Federica Monaco, Nicola Manzella, Jakub Rohlena, Katerina Rohlenova, Sara Staffolani, Simona Gaetani, Veronica Ciarapica, Monica Amati, Massimo Bracci, Matteo Valentino, Jacob Goodwin, Maria Nguyen, Jaroslav Truksa, Margaryta Sobol, Pavel Hozak, Lan-Feng Dong, Lory Santarelli, Jiri Neuzil
Review
Cell & Tissue Engineering
Oliver Trusler, Ziyi Huang, Jacob Goodwin, Andrew L. Laslett
STEM CELL RESEARCH
(2018)
Article
Multidisciplinary Sciences
Jack W. Lambshead, Laurence Meagher, Jacob Goodwin, Tanya Labonne, Elizabeth Ng, Andrew Elefanty, Edouard Stanley, Carmel M. O'Brien, Andrew L. Laslett
SCIENTIFIC REPORTS
(2018)
Article
Biochemistry & Molecular Biology
Michael Stapelberg, Renata Zobalova, Maria Nga Nguyen, Tom Walker, Marina Stantic, Jacob Goodwin, Elham Alizadeh Pasdar, Thuan Thai, Katerina Prokopova, Bing Yan, Susan Hall, Nicholas de Pennington, Shane R. Thomas, Gary Grant, Jan Stursa, Martina Bajzikova, Adrian C. B. Meedeniya, Jaroslav Truksa, Stephen J. Ralph, Olaf Ansorge, Lan-Feng Dong, Jiri Neuzil
FREE RADICAL BIOLOGY AND MEDICINE
(2014)
Article
Multidisciplinary Sciences
Elham Alizadeh Pasdar, Michael Smits, Michael Stapelberg, Martina Bajzikova, Marina Stantic, Jacob Goodwin, Bing Yan, Jan Stursa, Jaromira Kovarova, Karishma Sachaphibulkij, Ayenachew Bezawork-Geleta, Margaryta Sobol, Anatoly Filimonenko, Marco Tomasetti, Renata Zobalova, Pavel Hozak, Lan-Feng Dong, Jiri Neuzil
Article
Biochemistry & Molecular Biology
Jaromira Kovarova, Martina Bajzikova, Magdalena Vondrusova, Jan Stursa, Jacob Goodwin, Maria Nguyen, Renata Zobalova, Elham Alizadeh Pesdar, Jaroslav Truksa, Marco Tomasetti, Lan-Feng Dong, Jiri Neuzil
Article
Cell Biology
Fan Zhang, Siti Mariam Zakaria, Vedrana Hogqvist Tabor, Madhurendra Singh, Susanna Tronnersjo, Jacob Goodwin, Galina Selivanova, Jiri Bartek, Alina Castell, Lars-Gunnar Larsson
Article
Biochemistry & Molecular Biology
Katerina Rohlenova, Karishma Sachaphibulkij, Jan Stursa, Ayenachew Bezawork-Geleta, Jan Blecha, Berwini Endaya, Lukas Werner, Jiri Cerny, Renata Zobalova, Jacob Goodwin, Tomas Spacek, Elham Alizadeh Pesdar, Bing Yan, Maria Nga Nguyen, Magdalena Vondrusova, Margaryta Sobol, Petr Jezek, Pavel Hozak, Jaroslav Truksa, Jakub Rohlena, Lan-Feng Dong, Jiri Neuzil
ANTIOXIDANTS & REDOX SIGNALING
(2017)
Review
Biochemistry & Molecular Biology
Shamini Vijayakumaran, Mathew B. Wong, Helma Antony, Dean L. Pountney
Review
Biochemistry & Molecular Biology
Alex Rcom-H'cheo-Gauthier, Jacob Goodwin, Dean L. Pountney